Filter
1583
Text search:
drug
market
Featured
Recommendations
131
New Publications
465
Language
Document type
No document type
878
Studies & Reports
297
Guidelines
193
Strategic & Response Plan
87
Manuals
75
Fact sheets
22
Training Material
16
Situation Updates
7
Resource Platforms
5
Brochures
1
App
1
Infographics
1
Countries / Regions
India
80
Global
65
Kenya
61
Ethiopia
51
Uganda
48
Western and Central Europe
40
Ghana
37
Nigeria
36
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Sierra Leone
29
Zambia
26
Malawi
26
South Africa
25
Africa
25
Nepal
21
Tanzania
21
Philippines
20
Rwanda
18
Ukraine
17
Latin America and the Carribbean
17
Congo, Democratic Republic of
16
Zimbabwe
15
Cambodia
14
Asia
13
Namibia
12
South–East Asia Region
12
Eastern Europe
12
Indonesia
10
Venezuela
10
Senegal
9
Syria
9
Guinea
8
Brazil
8
Botswana
8
Lesotho
8
Mozambique
7
Burkina Faso
6
Cameroon
6
Thailand
6
China
6
Albania
6
Russia
6
Haiti
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Vietnam
5
South Sudan
4
Sudan
4
Colombia
4
Sri Lanka
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Germany
3
Benin
3
Peru
3
North Macedonia
3
Mexico
3
Middle East and North Africa
3
Laos
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Somalia
2
Pakistan
2
Jordan
2
Lebanon
2
Central African Republic
2
Argentina
2
Hungary
2
Libya
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Iran
2
Morocco
1
Iraq
1
Afghanistan
1
Papua New Guinea
1
Switzerland
1
Serbia
1
Bolivia
1
Madagascar
1
Chile
1
Fiji
1
Bhutan
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
101
Public Health
71
Key Resources
54
Pharmacy & Technologies
41
Women & Child Health
40
Capacity Building
13
Toolboxes
HIV
151
Mental Health
135
AMR
131
TB
104
Pharmacy
103
COVID-19
70
NTDs
41
Malaria
30
Planetary Health
28
Health Financing Toolbox
26
Conflict
25
Ebola & Marburg
23
Global Health Education
22
NCDs
22
Disability
18
Refugee
18
Caregiver
16
Rapid Response
13
Cholera
12
2.0 Rapid Response
7
Natural Hazards
6
Social Ethics
4
Polio
3
Specific Hazards
3
Tuberculosis cases, TB deaths
Strategy for Increasing the use of Modern Contraceptives in Nigeria
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m
...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t
...
For this report, the Task Force commissioned
additional background papers on health taxes to
update the evidence, assess short-term revenue
potential, and understand the role of health taxes
in the current era of multiple crises. We find that
health taxes continue to be underutilized despite th
...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
The document outlines essential steps and provides guidance to countries on the adoption and deployment of c-IPTp so that it is integrated into the existing health system. It draws upon best practices and lessons learned from pilot implementation experiences in eight African countries and targets st
...
Report of a virtual meeting 21–23 June 2022
Preferred product characteristics and clinical development considerations
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness
...
The overall objective of this approach is to accelerate efforts toward malaria elimination by increasing
access to early diagnosis and treatment. The specific objectives are to: Minimize the barriers that the population faces in accessing timely, quality diagnosis and treatment. Reduce the time bet
...
2023 was another year of significant progress in the fight against HIV, tuberculosis (TB) and malaria. In countries where the Global
Fund invests, there has been a full recovery from the disruptive impact of the COVID-19 pandemic. The results we have achieved in the last year build on our extraord
...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant
...
Non-Communicable Diseases (NCDs) have emerged as conditions of great public health concern in Kenya accounting for 39% of deaths annually. The Ministry of Health through the Department of Non-Communicable Diseases has adopted the vision of achieving a nation free from preventable burden of NCDs. Fur
...
Adolescents and young adults aged 10-24 remain underserved in the global response against HIV. Combination prevention, treatment and care programmes use a mix of evidence-based interventions to meet the current HIV prevention needs of adolescents and young adults. However, there needs to be a focus
...
